Results 1 to 10 of about 3,419,245 (305)

Comparison of resting-state EEG between adults with Down syndrome and typically developing controls

Journal of Neurodevelopmental Disorders, 2021
Background Down syndrome (DS) is the most common genetic cause of intellectual disability (ID) worldwide. Understanding electrophysiological characteristics associated with DS provides potential mechanistic insights into ID, helping inform biomarkers and
Sarah Hamburg, Daniel Bush, Andre Strydom, Carla M. Startin   +3 more
doaj   +1 more source

Evaluation of congenital and acquired heart diseases in a Spanish cohort of adults with Down syndrome

Scientific Reports, 2022
To describe congenital and acquired heart diseases in a Spanish cohort of adults with Down syndrome (DS), which could inform potential health recommendations for this population.
Laura Rabes, Laura Adán-Lirola, María del Pilar González-Molina, José María Galván-Román, Fernando Moldenhauer, Emilia Roy-Vallejo, Diego Real de Asúa   +6 more
doaj   +1 more source

Lipid profile of Mexican children with Down syndrome

BMC Pediatrics, 2021
Introduction Down syndrome (DS) is associated with various congenital anomalies and metabolic alterations, such as dyslipidemias, that can lead to cardiovascular disease in adulthood.
Silvestre Garcia-de la Puente, Karla A. Flores-Arizmendi, María J. Delgado-Montemayor, Tania T. Vargas-Robledo   +3 more
doaj   +1 more source

Blood cytology in children with down syndrome

BMC Pediatrics, 2022
Introduction Down syndrome is associated with various congenital anomalies and metabolic alterations such as hematological alterations. Values for the major hematological indicators vary with age and sex, but these values have not been described for ...
Silvestre García de la Puente, Karla Adney Flores-Arizmendi, Yessica Yuliana Guerrero-Tapia, Tania Tonantzin Vargas-Robledo, Norma Candelaria López-Santiago   +4 more
doaj   +1 more source

Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition

Alzheimer’s Research & Therapy, 2022
Background The apolipoprotein E (APOE) ε4 allele confers the strongest risk for late-onset Alzheimer’s disease (AD) besides age itself, but the mechanisms underlying this risk are debated.
Noah R. Johnson, Athena C.-J. Wang, Christina Coughlan, Stefan Sillau, Esteban Lucero, Lisa Viltz, Neil Markham, Cody Allen, A. Ranjitha Dhanasekaran, Heidi J. Chial, Huntington Potter   +10 more
doaj   +1 more source

Intracerebral haemorrhage in Down syndrome: protected or predisposed? [version 1; referees: 2 approved]

F1000Research, 2016
Down syndrome (DS), which arises from trisomy of chromosome 21, is associated with deposition of large amounts of amyloid within the central nervous system.
Lewis Buss, Elizabeth Fisher, John Hardy, Dean Nizetic, Jurgen Groet, Laura Pulford, André Strydom   +6 more
doaj   +1 more source

PPM1D suppresses p53-dependent transactivation and cell death by inhibiting the Integrated Stress Response

Nature Communications, 2022
The authors describe a functional crosstalk between the p53 network and the integrated stress response through the p53 repressor PPM1D. Inhibition of PPM1D potentiates p53-dependent transactivation and apoptosis via induction of the HRI-eIF2α-ATF4 ...
Zdenek Andrysik, Kelly D. Sullivan, Jeffrey S. Kieft, Joaquin M. Espinosa   +3 more
doaj   +1 more source

The co-construction of a reading assessment measure with adults with Down syndrome: a meaningful literacy approach

Frontiers in Psychology, 2023
IntroductionThe need to develop appropriate measures of broad-based reading-related literacy skills for adults with Down syndrome has been highlighted in the literature.
Pauline Frizelle, Sean O’Donovan, Mary Jolley, Lisa Martin, Nicola Hart   +4 more
doaj   +1 more source

Health comorbidities and cognitive abilities across the lifespan in Down syndrome

Journal of Neurodevelopmental Disorders, 2020
Background Down syndrome (DS) is associated with variable intellectual disability and multiple health and psychiatric comorbidities. The impact of such comorbidities on cognitive outcomes is unknown.
Carla M. Startin, Hana D’Souza, George Ball, Sarah Hamburg, Rosalyn Hithersay, Kate M. O. Hughes, Esha Massand, Annette Karmiloff-Smith, Michael S. C. Thomas, LonDownS Consortium, Andre Strydom   +10 more
doaj   +1 more source

JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome

Cell Reports, 2020
Summary: Individuals with Down syndrome (DS; trisomy 21) display hyperactivation of interferon (IFN) signaling and chronic inflammation, which could potentially be explained by the extra copy of four IFN receptor (IFNR) genes encoded on chromosome 21 ...
Kathryn D. Tuttle, Katherine A. Waugh, Paula Araya, Ross Minter, David J. Orlicky, Michael Ludwig, Zdenek Andrysik, Matthew A. Burchill, Beth A.J. Tamburini, Colin Sempeck, Keith Smith, Ross Granrath, Dayna Tracy, Jessica Baxter, Joaquin M. Espinosa, Kelly D. Sullivan   +15 more
doaj   +1 more source